CHJ.43331
Lysostaphin from Staphylococcus staphylolyticus
--
--
Ordering
Available Variants0.5 mg
CHJ.43331-0.5mg
Price
€176.00
Available – Dispatch in 14 days
2 mg
CHJ.43331-2mg
Price
€472.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
0.5 mg | CHJ.43331-0.5mg | €176.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
2 mg | CHJ.43331-2mg | €472.80 |
BioUltra, ≥97% (SDS-PAGE), Protein 40-60 % by biuret, ≥2,000 units/mg protein
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| CAS Number | 9011-93-2 |
|---|---|
| UNSPSC Code | 12352204 |
| NACRES | NA.54 |
| EC Number | 3.4.24.75 (BRENDA, IUBMB) |
| MDL number | MFCD00131556 |
| Specific activity | ≥2,000 units/mg protein |
| Assay | ≥97% (SDS-PAGE) |
| Biological source | bacterial (Staphylococcus sp.) |
| Concentration | 40—60% protein |
Safety Information Handling visibility
| pictograms |
GHS08
GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H334 |
| pcodes | P261 - P284 - P304 + P340 + P312 - P501 |
| Hazard Classifications | Resp. Sens. 1 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Gloves, type N95 (US) |
Technical Overview & Applications Use-case context
Lysostaphin, a glycylglycine endopeptidase, is an enzyme derived from Staphylococcus staphylolyticus with a CAS number of 9011-93-2. This bacteriolytic enzyme specifically targets and cleaves the pentaglycine crosslinks in the peptidoglycan layer of Staphylococcus cell walls, ultimately leading to cell lysis. The unique specificity of lysostaphin makes it an effective agent against Staphylococcus species, including methicillin-resistant Staphylococcus aureus. As a potential therapeutic agent, lysostaphin has been explored for its ability to treat Staphylococcus-related infections, particularly in cases where traditional antibiotics are ineffective. Further research is needed to fully understand the mechanisms and potential applications of lysostaphin, but its targeted bacteriolytic activity makes it a promising candidate for the development of novel antimicrobial therapies. Lysostaphins enzymatic properties and specificity also make it a valuable tool in microbiological research and diagnostics.
